Kamada Non Current Assets Total Over Time
| KMDA Stock | USD 5.75 0.19 3.42% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Kamada Performance and Kamada Correlation. Kamada |
Is Kamada's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kamada. If investors know Kamada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kamada listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.227 | Earnings Share 0.15 | Revenue Per Share 2.919 | Quarterly Revenue Growth (0.20) | Return On Assets 0.0186 |
The market value of Kamada is measured differently than its book value, which is the value of Kamada that is recorded on the company's balance sheet. Investors also form their own opinion of Kamada's value that differs from its market value or its book value, called intrinsic value, which is Kamada's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kamada's market value can be influenced by many factors that don't directly affect Kamada's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kamada's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kamada is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kamada's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Current Assets Total Analysis
Compare Kamada and related stocks such as Lifecore Biomedical, Shuttle Pharmaceuticals, and Cumberland Pharmaceuticals Non Current Assets Total Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LFCR | 1.1 M | 196.5 M | 205.3 M | 222.7 M | 253.3 M | 257 M | 276.7 M | 307.6 M | 386.1 M | 384.2 M | 354.6 M | 171.4 M | 171.4 M | 197.2 M | 160.7 M |
| SHPH | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 142 K | 75.2 K | 358.7 K | 214.2 K |
| CPIX | 1.6 M | 8.2 M | 11.4 M | 18.9 M | 24.6 M | 24.8 M | 27.9 M | 24.5 M | 37.8 M | 54.4 M | 46.5 M | 38.8 M | 47.1 M | 46.1 M | 27.5 M |
| IRWD | 16.7 M | 41.4 M | 45.5 M | 49.8 M | 43.8 M | 118.9 M | 329.6 M | 294.1 M | 65.6 M | 95.9 M | 63.4 M | 381.7 M | 319.9 M | 237.8 M | 143 M |
| ORGO | 290.2 K | 290.2 K | 290.2 K | 290.2 K | 290.2 K | 290.2 K | 310 M | 312.5 M | 92.5 M | 95.1 M | 120.2 M | 216.3 M | 226.8 M | 235 M | 196.6 M |
| LSDI | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 3.5 M | 2.7 M | 5 M | 5.7 M | 3.1 M |
| ALIM | 424 K | 197 K | 114 K | 982 K | 26.1 M | 25.3 M | 22.8 M | 20.6 M | 19.3 M | 17.6 M | 15.9 M | 16.4 M | 13.2 M | 101.1 M | 106.2 M |
| GHSI | 181.3 K | 181.3 K | 181.3 K | 181.3 K | 181.3 K | 181.3 K | 124.5 K | 2.3 M | 2.6 M | 1 M | 766 K | 11.4 M | 48.9 K | 33.2 K | 31.6 K |
| AKAN | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 35.2 M | 40.5 M | 42.5 M |
| EVOK | 555.5 K | 555.5 K | 555.5 K | 555.5 K | 53 K | 8 K | 11.6 K | 11.6 K | 11.6 K | 150.1 K | 153.3 K | 12.4 K | 129.1 K | 241.6 K | 253.7 K |
| COLL | 773 K | 773 K | 773 K | 773 K | 594 K | 835 K | 3.4 M | 2.1 M | 53.7 M | 50.6 M | 366 M | 376.5 M | 754.1 M | 605.7 M | 636 M |
| RDY | 6.6 B | 49.5 B | 566.6 B | 66.5 B | 74.9 B | 88 B | 119.4 B | 116 B | 110.9 B | 101.9 B | 117.2 B | 115.5 B | 118.6 B | 136.4 B | 95.9 B |
| PCRX | 31.2 M | 30.8 M | 51.1 M | 63.1 M | 111.8 M | 137 M | 148.4 M | 237.3 M | 211.4 M | 422.5 M | 622.9 M | 1.2 B | 1.2 B | 1.1 B | 1.1 B |
| PRGO | 153.3 M | 2.2 B | 3.1 B | 11.3 B | 11.3 B | 16.5 B | 11.1 B | 8.8 B | 8.1 B | 8.5 B | 8.4 B | 6.6 B | 8.3 B | 8 B | 4.2 B |
| EGRX | 573.1 K | 573.1 K | 573.1 K | 620.2 K | 389 K | 2.3 M | 104.5 M | 81.4 M | 74.8 M | 75.1 M | 87.1 M | 81.1 M | 217.4 M | 250 M | 262.5 M |
| ANIP | 532.8 K | 4.4 M | 3.6 M | 16.8 M | 60.2 M | 92.7 M | 219.9 M | 280.5 M | 277.7 M | 269.1 M | 290.9 M | 449.8 M | 415.8 M | 384.8 M | 404 M |
| PAHC | 108.7 M | 139 M | 177.8 M | 173 M | 179.6 M | 267.5 M | 259.7 M | 256.2 M | 260.5 M | 332.3 M | 342.4 M | 365.5 M | 385.7 M | 443.5 M | 465.7 M |
| DCPH | 407 K | 407 K | 407 K | 407 K | 407 K | 407 K | 693 K | 913 K | 14.5 M | 29 M | 58.4 M | 90.5 M | 61.1 M | 92.5 M | 97.1 M |
| PBH | 295.9 M | 1.6 B | 1.6 B | 1.6 B | 2.5 B | 2.7 B | 3.6 B | 3.5 B | 3.1 B | 3.1 B | 3.2 B | 3.4 B | 3 B | 3.4 B | 2.2 B |
Kamada and related stocks such as Lifecore Biomedical, Shuttle Pharmaceuticals, and Cumberland Pharmaceuticals Non Current Assets Total description
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Kamada | KMDA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Israel |
| Exchange | NASDAQ Exchange |
USD 5.75
Check out Kamada Performance and Kamada Correlation. For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.Note that the Kamada information on this page should be used as a complementary analysis to other Kamada's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Kamada Stock analysis
When running Kamada's price analysis, check to measure Kamada's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kamada is operating at the current time. Most of Kamada's value examination focuses on studying past and present price action to predict the probability of Kamada's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kamada's price. Additionally, you may evaluate how the addition of Kamada to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Kamada technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.